FDA Class II Recall: Medtronic CareLink SmartSync Patient Connector, Model Number 24967… by Medtronic, Inc.

Key facts

What consumers should do

Facilities, clinicians, and consumers holding an affected unit or lot of Medtronic CareLink SmartSync Patient Connector, Model Number 24967 with the following software components: 1. Cobalt Crome application, Software Model Number D00U005; 2. Claria Amplia Compia application, Software Model Number D00U009; 3. Evera MRI application, Software Model Number D00U010; 3. Visia AF application, Software Model Number D00U011; 5. Viva Brava Evera application, Software Model Number D00U012; should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from Medtronic, Inc.. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from Medtronic, Inc. should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to Medtronic, Inc. directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.

What this classification means

A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. FDA still requires the recalling firm to notify affected accounts and submit status reports on the correction, though the monitoring intensity is lower than for a Class I recall. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class II, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.

Medtronic, Inc.’s FDA history

Argus HQ has recorded 40 total FDA actions tied to Medtronic, Inc.: 0 warning letters, 40 recalls, 0 approval records, and 0 Form 483 inspection citations.

Frequently asked questions

Where can I verify this recall directly with FDA?

The verbatim FDA record is the source of truth for every recall Argus HQ tracks — always confirm against fda.gov before acting.

Is Medtronic CareLink SmartSync Patient Connector, Model Number recalled?

Yes. FDA lists a Class II recall by Medtronic, Inc. for Medtronic CareLink SmartSync Patient Connector, Model Number 24967 with the following software components: 1. Cobalt Crome application, Software Model Number D00U005; 2. Claria Amplia Compia application, Software Model Number D00U009; 3. Evera MRI application, Software Model Number D00U010; 3. Visia AF application, Software Model Number D00U011; 5. Viva Brava Evera application, Software Model Number D00U012;, reported 20250730, with status "Ongoing." FDA recall number: Z-2168-2025.

What is the recall class for Medtronic, Inc.'s recall?

FDA classified this recall as Class II. A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

Why was Medtronic CareLink SmartSync Patient Connector, Model Number recalled?

FDA's recall record states the reason as: In prior SmartSync application versions, the Abort button stopped the test that was selected. During an induction test, there was a limited window of time for the user to abort a therapy, thereby limiting the user's ability to cancel a high voltage therapy delivery.

Related enforcement actions

• Recall: Medtronic Inc — Class II recall: Abre Venous Self-Expanding Stent System, Model numbers AB9G14120090 AB9G1210009… →
• Recall: Medtronic, Inc. — Class II recall: Aurora EV-ICD and Clinical EV-ICD, single chamber, extravascular implantable car… →
• Recall: Medtronic, Inc. — Class II recall: Medtronic CareLink SmartSync Device Manager, Model Number 24967A with the follow… →
• Recall: Medtronic, Inc. — Class II recall: Medtronic SmartLink Software loaded on SmartSync Patient Connector, Model Number… →
• Recall: Medtronic, Inc. — Class II recall: Medtronic SmartLink software loaded on CareLink SmartSync Device Manager, Model… →
• Recall: Medtronic, Inc. — Class II recall: Azure S DR MRI SureScan, Product number W3DR01 →
• Recall: Medtronic Inc. — Class II recall: 2090 Programmers with serial number prefixes PKK0 and PKK1: a) 2090, Product… →
• Recall: Medtronic Inc. — Class II recall: COBALT XT HF QUAD CRT-D MRI SureScan, Model Number DTPA2QQ, Implantable Cardiove… →